nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP2E1—lung cancer	0.188	0.656	CbGaD
Pimozide—ABCB1—lung cancer	0.0983	0.344	CbGaD
Pimozide—CYP3A5—Gefitinib—lung cancer	0.0196	0.0454	CbGbCtD
Pimozide—CYP3A5—Teniposide—lung cancer	0.019	0.044	CbGbCtD
Pimozide—CYP2C19—Gefitinib—lung cancer	0.0158	0.0366	CbGbCtD
Pimozide—CYP2C19—Teniposide—lung cancer	0.0153	0.0355	CbGbCtD
Pimozide—CYP3A7—Paclitaxel—lung cancer	0.0141	0.0327	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0141	0.0327	CbGbCtD
Pimozide—CYP3A7—Irinotecan—lung cancer	0.014	0.0323	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.014	0.0323	CbGbCtD
Pimozide—ABCB1—Topotecan—lung cancer	0.014	0.0323	CbGbCtD
Pimozide—ABCB1—Gefitinib—lung cancer	0.0128	0.0295	CbGbCtD
Pimozide—CYP2D6—Gefitinib—lung cancer	0.012	0.0278	CbGbCtD
Pimozide—CYP3A5—Crizotinib—lung cancer	0.012	0.0278	CbGbCtD
Pimozide—CYP3A5—Erlotinib—lung cancer	0.0116	0.0268	CbGbCtD
Pimozide—CYP2E1—Etoposide—lung cancer	0.0108	0.025	CbGbCtD
Pimozide—CYP3A5—Paclitaxel—lung cancer	0.0106	0.0246	CbGbCtD
Pimozide—CYP3A5—Irinotecan—lung cancer	0.0105	0.0242	CbGbCtD
Pimozide—CYP3A7—Docetaxel—lung cancer	0.0102	0.0237	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0102	0.0237	CbGbCtD
Pimozide—ABCB1—Vinorelbine—lung cancer	0.00983	0.0228	CbGbCtD
Pimozide—CYP2D6—Vinorelbine—lung cancer	0.00926	0.0214	CbGbCtD
Pimozide—CYP1A2—Erlotinib—lung cancer	0.00863	0.02	CbGbCtD
Pimozide—CYP3A5—Etoposide—lung cancer	0.00838	0.0194	CbGbCtD
Pimozide—CYP3A4—Topotecan—lung cancer	0.00836	0.0194	CbGbCtD
Pimozide—ABCB1—Crizotinib—lung cancer	0.00782	0.0181	CbGbCtD
Pimozide—CYP3A5—Docetaxel—lung cancer	0.00767	0.0178	CbGbCtD
Pimozide—CYP3A4—Gefitinib—lung cancer	0.00764	0.0177	CbGbCtD
Pimozide—ABCB1—Gemcitabine—lung cancer	0.00764	0.0177	CbGbCtD
Pimozide—ABCB1—Erlotinib—lung cancer	0.00754	0.0175	CbGbCtD
Pimozide—CYP3A4—Teniposide—lung cancer	0.00741	0.0172	CbGbCtD
Pimozide—CYP2D6—Erlotinib—lung cancer	0.00711	0.0165	CbGbCtD
Pimozide—ABCB1—Paclitaxel—lung cancer	0.00691	0.016	CbGbCtD
Pimozide—ABCB1—Irinotecan—lung cancer	0.00681	0.0158	CbGbCtD
Pimozide—CYP1A2—Etoposide—lung cancer	0.00624	0.0144	CbGbCtD
Pimozide—ABCB1—Vinblastine—lung cancer	0.00606	0.014	CbGbCtD
Pimozide—CYP3A4—Vinorelbine—lung cancer	0.00589	0.0136	CbGbCtD
Pimozide—CYP2D6—Vinblastine—lung cancer	0.00571	0.0132	CbGbCtD
Pimozide—ABCB1—Cisplatin—lung cancer	0.00555	0.0129	CbGbCtD
Pimozide—ABCB1—Etoposide—lung cancer	0.00546	0.0126	CbGbCtD
Pimozide—HTR2A—phrenic nerve—lung cancer	0.00532	0.22	CbGeAlD
Pimozide—ABCB1—Docetaxel—lung cancer	0.00499	0.0116	CbGbCtD
Pimozide—CYP3A4—Crizotinib—lung cancer	0.00469	0.0108	CbGbCtD
Pimozide—CYP3A4—Erlotinib—lung cancer	0.00452	0.0105	CbGbCtD
Pimozide—CYP3A4—Paclitaxel—lung cancer	0.00414	0.00958	CbGbCtD
Pimozide—CYP3A4—Irinotecan—lung cancer	0.00408	0.00945	CbGbCtD
Pimozide—ABCB1—Doxorubicin—lung cancer	0.00372	0.00862	CbGbCtD
Pimozide—CYP3A4—Vinblastine—lung cancer	0.00363	0.0084	CbGbCtD
Pimozide—ABCB1—Methotrexate—lung cancer	0.00361	0.00835	CbGbCtD
Pimozide—CYP2D6—Doxorubicin—lung cancer	0.00351	0.00812	CbGbCtD
Pimozide—CYP3A4—Etoposide—lung cancer	0.00327	0.00757	CbGbCtD
Pimozide—CYP3A4—Docetaxel—lung cancer	0.00299	0.00693	CbGbCtD
Pimozide—CYP3A4—Doxorubicin—lung cancer	0.00223	0.00516	CbGbCtD
Pimozide—HTR2A—pulmonary artery—lung cancer	0.00193	0.0799	CbGeAlD
Pimozide—Ezetimibe—ABCC3—lung cancer	0.00104	0.28	CrCbGaD
Pimozide—CALM3—mammary gland—lung cancer	0.00102	0.0423	CbGeAlD
Pimozide—Ezetimibe—UGT1A1—lung cancer	0.000901	0.242	CrCbGaD
Pimozide—CALM1—mammary gland—lung cancer	0.000801	0.0331	CbGeAlD
Pimozide—CALM3—bronchus—lung cancer	0.000562	0.0232	CbGeAlD
Pimozide—CALM2—respiratory system—lung cancer	0.000536	0.0222	CbGeAlD
Pimozide—CALM1—respiratory system—lung cancer	0.000534	0.0221	CbGeAlD
Pimozide—Ezetimibe—ABCG2—lung cancer	0.000507	0.136	CrCbGaD
Pimozide—CALM3—trachea—lung cancer	0.000504	0.0209	CbGeAlD
Pimozide—DRD2—respiratory system—lung cancer	0.000493	0.0204	CbGeAlD
Pimozide—CALM3—cardiac atrium—lung cancer	0.000474	0.0196	CbGeAlD
Pimozide—CALM2—epithelium—lung cancer	0.000448	0.0185	CbGeAlD
Pimozide—CALM1—epithelium—lung cancer	0.000446	0.0184	CbGeAlD
Pimozide—CALM2—bronchus—lung cancer	0.000441	0.0182	CbGeAlD
Pimozide—CALM1—bronchus—lung cancer	0.000439	0.0182	CbGeAlD
Pimozide—CYP1A2—respiratory system—lung cancer	0.000416	0.0172	CbGeAlD
Pimozide—CYP3A5—respiratory system—lung cancer	0.000401	0.0166	CbGeAlD
Pimozide—CALM3—bone marrow—lung cancer	0.0004	0.0165	CbGeAlD
Pimozide—CALM2—trachea—lung cancer	0.000396	0.0164	CbGeAlD
Pimozide—CALM1—trachea—lung cancer	0.000394	0.0163	CbGeAlD
Pimozide—HRH1—respiratory system—lung cancer	0.000389	0.0161	CbGeAlD
Pimozide—CYP2E1—respiratory system—lung cancer	0.000374	0.0155	CbGeAlD
Pimozide—CALM2—cardiac atrium—lung cancer	0.000372	0.0154	CbGeAlD
Pimozide—CALM1—cardiac atrium—lung cancer	0.00037	0.0153	CbGeAlD
Pimozide—CALM3—lung—lung cancer	0.000362	0.015	CbGeAlD
Pimozide—KCNH2—cardiac atrium—lung cancer	0.000337	0.0139	CbGeAlD
Pimozide—Flunarizine—CYP2A6—lung cancer	0.000334	0.0895	CrCbGaD
Pimozide—HRH1—epithelium—lung cancer	0.000325	0.0134	CbGeAlD
Pimozide—HTR2A—respiratory system—lung cancer	0.000325	0.0134	CbGeAlD
Pimozide—CALM2—bone marrow—lung cancer	0.000314	0.013	CbGeAlD
Pimozide—CALM1—bone marrow—lung cancer	0.000313	0.0129	CbGeAlD
Pimozide—HRH1—trachea—lung cancer	0.000288	0.0119	CbGeAlD
Pimozide—CALM2—lung—lung cancer	0.000285	0.0118	CbGeAlD
Pimozide—KCNH2—bone marrow—lung cancer	0.000285	0.0118	CbGeAlD
Pimozide—CALM1—lung—lung cancer	0.000283	0.0117	CbGeAlD
Pimozide—HTR2A—epithelium—lung cancer	0.000272	0.0112	CbGeAlD
Pimozide—DRD2—lung—lung cancer	0.000262	0.0108	CbGeAlD
Pimozide—CALM3—lymph node—lung cancer	0.000248	0.0102	CbGeAlD
Pimozide—HTR2A—trachea—lung cancer	0.00024	0.00993	CbGeAlD
Pimozide—Flunarizine—CYP1A1—lung cancer	0.000234	0.0627	CrCbGaD
Pimozide—CYP1A2—lung—lung cancer	0.000221	0.00912	CbGeAlD
Pimozide—ABCB1—respiratory system—lung cancer	0.000213	0.0088	CbGeAlD
Pimozide—CYP3A5—lung—lung cancer	0.000213	0.0088	CbGeAlD
Pimozide—Astemizole—ABCB1—lung cancer	0.000211	0.0566	CrCbGaD
Pimozide—Ezetimibe—ABCB1—lung cancer	0.000211	0.0566	CrCbGaD
Pimozide—HRH1—lung—lung cancer	0.000207	0.00854	CbGeAlD
Pimozide—CYP2E1—lung—lung cancer	0.000199	0.00821	CbGeAlD
Pimozide—CALM2—lymph node—lung cancer	0.000195	0.00805	CbGeAlD
Pimozide—CALM1—lymph node—lung cancer	0.000194	0.00801	CbGeAlD
Pimozide—ABCB1—epithelium—lung cancer	0.000178	0.00736	CbGeAlD
Pimozide—KCNH2—lymph node—lung cancer	0.000176	0.00729	CbGeAlD
Pimozide—HTR2A—lung—lung cancer	0.000173	0.00713	CbGeAlD
Pimozide—ABCB1—trachea—lung cancer	0.000157	0.00651	CbGeAlD
Pimozide—Fexofenadine—ABCB1—lung cancer	0.00015	0.0403	CrCbGaD
Pimozide—HRH1—lymph node—lung cancer	0.000141	0.00584	CbGeAlD
Pimozide—Domperidone—ABCB1—lung cancer	0.000137	0.0368	CrCbGaD
Pimozide—Leukopenia—Etoposide—lung cancer	0.000132	0.00117	CcSEcCtD
Pimozide—Hypotension—Gemcitabine—lung cancer	0.000132	0.00117	CcSEcCtD
Pimozide—Eye disorder—Docetaxel—lung cancer	0.000132	0.00117	CcSEcCtD
Pimozide—Insomnia—Irinotecan—lung cancer	0.000131	0.00116	CcSEcCtD
Pimozide—Cardiac disorder—Docetaxel—lung cancer	0.000131	0.00116	CcSEcCtD
Pimozide—Vomiting—Topotecan—lung cancer	0.000131	0.00116	CcSEcCtD
Pimozide—Syncope—Paclitaxel—lung cancer	0.00013	0.00115	CcSEcCtD
Pimozide—Loss of consciousness—Etoposide—lung cancer	0.00013	0.00115	CcSEcCtD
Pimozide—Leukopenia—Paclitaxel—lung cancer	0.00013	0.00115	CcSEcCtD
Pimozide—Rash—Topotecan—lung cancer	0.00013	0.00115	CcSEcCtD
Pimozide—Dermatitis—Topotecan—lung cancer	0.00013	0.00115	CcSEcCtD
Pimozide—Vomiting—Erlotinib—lung cancer	0.000129	0.00115	CcSEcCtD
Pimozide—Nervous system disorder—Cisplatin—lung cancer	0.000129	0.00114	CcSEcCtD
Pimozide—Somnolence—Irinotecan—lung cancer	0.000129	0.00114	CcSEcCtD
Pimozide—Headache—Topotecan—lung cancer	0.000129	0.00114	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000129	0.00114	CcSEcCtD
Pimozide—Tachycardia—Cisplatin—lung cancer	0.000129	0.00114	CcSEcCtD
Pimozide—Rash—Erlotinib—lung cancer	0.000128	0.00114	CcSEcCtD
Pimozide—Dermatitis—Erlotinib—lung cancer	0.000128	0.00114	CcSEcCtD
Pimozide—Palpitations—Paclitaxel—lung cancer	0.000128	0.00113	CcSEcCtD
Pimozide—Convulsion—Etoposide—lung cancer	0.000128	0.00113	CcSEcCtD
Pimozide—Skin disorder—Cisplatin—lung cancer	0.000128	0.00113	CcSEcCtD
Pimozide—Hyponatraemia—Doxorubicin—lung cancer	0.000128	0.00113	CcSEcCtD
Pimozide—Insomnia—Gemcitabine—lung cancer	0.000128	0.00113	CcSEcCtD
Pimozide—Hypertension—Etoposide—lung cancer	0.000128	0.00113	CcSEcCtD
Pimozide—Headache—Erlotinib—lung cancer	0.000127	0.00113	CcSEcCtD
Pimozide—Loss of consciousness—Paclitaxel—lung cancer	0.000127	0.00113	CcSEcCtD
Pimozide—Hyperhidrosis—Cisplatin—lung cancer	0.000127	0.00113	CcSEcCtD
Pimozide—Asthenia—Vinorelbine—lung cancer	0.000126	0.00112	CcSEcCtD
Pimozide—Decreased appetite—Irinotecan—lung cancer	0.000126	0.00112	CcSEcCtD
Pimozide—Chest pain—Etoposide—lung cancer	0.000126	0.00112	CcSEcCtD
Pimozide—Eosinophilia—Methotrexate—lung cancer	0.000126	0.00111	CcSEcCtD
Pimozide—Nausea—Vinblastine—lung cancer	0.000126	0.00111	CcSEcCtD
Pimozide—Somnolence—Gemcitabine—lung cancer	0.000126	0.00111	CcSEcCtD
Pimozide—Convulsion—Paclitaxel—lung cancer	0.000126	0.00111	CcSEcCtD
Pimozide—Anorexia—Cisplatin—lung cancer	0.000126	0.00111	CcSEcCtD
Pimozide—Gastrointestinal disorder—Irinotecan—lung cancer	0.000125	0.00111	CcSEcCtD
Pimozide—Hypertension—Paclitaxel—lung cancer	0.000125	0.00111	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000125	0.00111	CcSEcCtD
Pimozide—ABCB1—bone marrow—lung cancer	0.000125	0.00516	CbGeAlD
Pimozide—Pruritus—Vinorelbine—lung cancer	0.000124	0.0011	CcSEcCtD
Pimozide—Constipation—Irinotecan—lung cancer	0.000124	0.0011	CcSEcCtD
Pimozide—Mental disorder—Docetaxel—lung cancer	0.000124	0.0011	CcSEcCtD
Pimozide—Chest pain—Paclitaxel—lung cancer	0.000123	0.00109	CcSEcCtD
Pimozide—Myalgia—Paclitaxel—lung cancer	0.000123	0.00109	CcSEcCtD
Pimozide—Hypotension—Cisplatin—lung cancer	0.000123	0.00109	CcSEcCtD
Pimozide—Decreased appetite—Gemcitabine—lung cancer	0.000123	0.00109	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000123	0.00109	CcSEcCtD
Pimozide—Nausea—Topotecan—lung cancer	0.000122	0.00108	CcSEcCtD
Pimozide—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000122	0.00108	CcSEcCtD
Pimozide—Abdominal discomfort—Methotrexate—lung cancer	0.000122	0.00108	CcSEcCtD
Pimozide—Constipation—Gemcitabine—lung cancer	0.000121	0.00107	CcSEcCtD
Pimozide—Nausea—Erlotinib—lung cancer	0.000121	0.00107	CcSEcCtD
Pimozide—Pancytopenia—Methotrexate—lung cancer	0.000121	0.00107	CcSEcCtD
Pimozide—Dry mouth—Paclitaxel—lung cancer	0.000121	0.00107	CcSEcCtD
Pimozide—Diarrhoea—Vinorelbine—lung cancer	0.00012	0.00107	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Cisplatin—lung cancer	0.00012	0.00106	CcSEcCtD
Pimozide—Muscle spasms—Docetaxel—lung cancer	0.000118	0.00105	CcSEcCtD
Pimozide—Tachycardia—Etoposide—lung cancer	0.000118	0.00104	CcSEcCtD
Pimozide—Skin disorder—Etoposide—lung cancer	0.000117	0.00104	CcSEcCtD
Pimozide—Erectile dysfunction—Methotrexate—lung cancer	0.000117	0.00104	CcSEcCtD
Pimozide—Hyperhidrosis—Etoposide—lung cancer	0.000117	0.00103	CcSEcCtD
Pimozide—Shock—Paclitaxel—lung cancer	0.000116	0.00103	CcSEcCtD
Pimozide—Dizziness—Vinorelbine—lung cancer	0.000116	0.00103	CcSEcCtD
Pimozide—Orthostatic hypotension—Doxorubicin—lung cancer	0.000116	0.00103	CcSEcCtD
Pimozide—Nervous system disorder—Paclitaxel—lung cancer	0.000116	0.00103	CcSEcCtD
Pimozide—Tachycardia—Paclitaxel—lung cancer	0.000115	0.00102	CcSEcCtD
Pimozide—Breast disorder—Doxorubicin—lung cancer	0.000115	0.00102	CcSEcCtD
Pimozide—Anorexia—Etoposide—lung cancer	0.000115	0.00102	CcSEcCtD
Pimozide—Skin disorder—Paclitaxel—lung cancer	0.000115	0.00102	CcSEcCtD
Pimozide—Decreased appetite—Cisplatin—lung cancer	0.000115	0.00101	CcSEcCtD
Pimozide—Hyperhidrosis—Paclitaxel—lung cancer	0.000114	0.00101	CcSEcCtD
Pimozide—Gastrointestinal disorder—Cisplatin—lung cancer	0.000114	0.00101	CcSEcCtD
Pimozide—Anaemia—Docetaxel—lung cancer	0.000114	0.00101	CcSEcCtD
Pimozide—Drowsiness—Methotrexate—lung cancer	0.000113	0.001	CcSEcCtD
Pimozide—ABCB1—lung—lung cancer	0.000113	0.00468	CbGeAlD
Pimozide—Depression—Methotrexate—lung cancer	0.000113	0.001	CcSEcCtD
Pimozide—Anorexia—Paclitaxel—lung cancer	0.000113	0.000999	CcSEcCtD
Pimozide—Hypotension—Etoposide—lung cancer	0.000113	0.000999	CcSEcCtD
Pimozide—Vomiting—Vinorelbine—lung cancer	0.000112	0.000991	CcSEcCtD
Pimozide—Rash—Vinorelbine—lung cancer	0.000111	0.000983	CcSEcCtD
Pimozide—Dermatitis—Vinorelbine—lung cancer	0.000111	0.000982	CcSEcCtD
Pimozide—Hypotension—Paclitaxel—lung cancer	0.000111	0.000979	CcSEcCtD
Pimozide—Headache—Vinorelbine—lung cancer	0.00011	0.000976	CcSEcCtD
Pimozide—Syncope—Docetaxel—lung cancer	0.00011	0.000976	CcSEcCtD
Pimozide—Dysphagia—Doxorubicin—lung cancer	0.00011	0.000975	CcSEcCtD
Pimozide—Leukopenia—Docetaxel—lung cancer	0.00011	0.000974	CcSEcCtD
Pimozide—Eosinophilia—Doxorubicin—lung cancer	0.000109	0.000965	CcSEcCtD
Pimozide—Sweating—Methotrexate—lung cancer	0.000109	0.000963	CcSEcCtD
Pimozide—Palpitations—Docetaxel—lung cancer	0.000109	0.000962	CcSEcCtD
Pimozide—Loss of consciousness—Docetaxel—lung cancer	0.000108	0.000957	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000108	0.000955	CcSEcCtD
Pimozide—Somnolence—Etoposide—lung cancer	0.000107	0.00095	CcSEcCtD
Pimozide—Insomnia—Paclitaxel—lung cancer	0.000107	0.000948	CcSEcCtD
Pimozide—Convulsion—Docetaxel—lung cancer	0.000106	0.000943	CcSEcCtD
Pimozide—Hypertension—Docetaxel—lung cancer	0.000106	0.00094	CcSEcCtD
Pimozide—Agranulocytosis—Methotrexate—lung cancer	0.000106	0.000937	CcSEcCtD
Pimozide—Somnolence—Paclitaxel—lung cancer	0.000105	0.000932	CcSEcCtD
Pimozide—Decreased appetite—Etoposide—lung cancer	0.000105	0.000929	CcSEcCtD
Pimozide—Chest pain—Docetaxel—lung cancer	0.000105	0.000927	CcSEcCtD
Pimozide—Myalgia—Docetaxel—lung cancer	0.000105	0.000927	CcSEcCtD
Pimozide—Pancytopenia—Doxorubicin—lung cancer	0.000105	0.000926	CcSEcCtD
Pimozide—Nausea—Vinorelbine—lung cancer	0.000104	0.000926	CcSEcCtD
Pimozide—Gastrointestinal disorder—Etoposide—lung cancer	0.000104	0.000923	CcSEcCtD
Pimozide—Asthenia—Irinotecan—lung cancer	0.000104	0.000922	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000104	0.00092	CcSEcCtD
Pimozide—Constipation—Etoposide—lung cancer	0.000103	0.000914	CcSEcCtD
Pimozide—Decreased appetite—Paclitaxel—lung cancer	0.000103	0.000911	CcSEcCtD
Pimozide—Dry mouth—Docetaxel—lung cancer	0.000102	0.000906	CcSEcCtD
Pimozide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000102	0.000905	CcSEcCtD
Pimozide—Pollakiuria—Doxorubicin—lung cancer	0.000102	0.000901	CcSEcCtD
Pimozide—Asthenia—Gemcitabine—lung cancer	0.000101	0.000898	CcSEcCtD
Pimozide—Constipation—Paclitaxel—lung cancer	0.000101	0.000896	CcSEcCtD
Pimozide—Weight increased—Doxorubicin—lung cancer	0.0001	0.000887	CcSEcCtD
Pimozide—Pruritus—Gemcitabine—lung cancer	0.0001	0.000886	CcSEcCtD
Pimozide—Weight decreased—Doxorubicin—lung cancer	9.96e-05	0.000882	CcSEcCtD
Pimozide—Diarrhoea—Irinotecan—lung cancer	9.93e-05	0.000879	CcSEcCtD
Pimozide—Shock—Docetaxel—lung cancer	9.87e-05	0.000874	CcSEcCtD
Pimozide—Nervous system disorder—Docetaxel—lung cancer	9.84e-05	0.000871	CcSEcCtD
Pimozide—Drowsiness—Doxorubicin—lung cancer	9.81e-05	0.000869	CcSEcCtD
Pimozide—Visual impairment—Methotrexate—lung cancer	9.8e-05	0.000869	CcSEcCtD
Pimozide—Tachycardia—Docetaxel—lung cancer	9.79e-05	0.000867	CcSEcCtD
Pimozide—Skin disorder—Docetaxel—lung cancer	9.74e-05	0.000863	CcSEcCtD
Pimozide—Diarrhoea—Gemcitabine—lung cancer	9.67e-05	0.000857	CcSEcCtD
Pimozide—Dizziness—Irinotecan—lung cancer	9.59e-05	0.00085	CcSEcCtD
Pimozide—Urticaria—Etoposide—lung cancer	9.59e-05	0.000849	CcSEcCtD
Pimozide—Anorexia—Docetaxel—lung cancer	9.56e-05	0.000847	CcSEcCtD
Pimozide—Eye disorder—Methotrexate—lung cancer	9.51e-05	0.000842	CcSEcCtD
Pimozide—Asthenia—Cisplatin—lung cancer	9.45e-05	0.000837	CcSEcCtD
Pimozide—Cardiac disorder—Methotrexate—lung cancer	9.44e-05	0.000836	CcSEcCtD
Pimozide—Sweating—Doxorubicin—lung cancer	9.41e-05	0.000833	CcSEcCtD
Pimozide—Urticaria—Paclitaxel—lung cancer	9.4e-05	0.000833	CcSEcCtD
Pimozide—Hypotension—Docetaxel—lung cancer	9.37e-05	0.00083	CcSEcCtD
Pimozide—Vomiting—Irinotecan—lung cancer	9.22e-05	0.000817	CcSEcCtD
Pimozide—Agranulocytosis—Doxorubicin—lung cancer	9.16e-05	0.000811	CcSEcCtD
Pimozide—Rash—Irinotecan—lung cancer	9.15e-05	0.00081	CcSEcCtD
Pimozide—Dermatitis—Irinotecan—lung cancer	9.14e-05	0.00081	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Docetaxel—lung cancer	9.14e-05	0.000809	CcSEcCtD
Pimozide—Headache—Irinotecan—lung cancer	9.09e-05	0.000805	CcSEcCtD
Pimozide—Insomnia—Docetaxel—lung cancer	9.07e-05	0.000804	CcSEcCtD
Pimozide—Diarrhoea—Cisplatin—lung cancer	9.01e-05	0.000798	CcSEcCtD
Pimozide—Vomiting—Gemcitabine—lung cancer	8.99e-05	0.000796	CcSEcCtD
Pimozide—Somnolence—Docetaxel—lung cancer	8.92e-05	0.00079	CcSEcCtD
Pimozide—Mental disorder—Methotrexate—lung cancer	8.91e-05	0.00079	CcSEcCtD
Pimozide—Rash—Gemcitabine—lung cancer	8.91e-05	0.000789	CcSEcCtD
Pimozide—Dermatitis—Gemcitabine—lung cancer	8.9e-05	0.000789	CcSEcCtD
Pimozide—Headache—Gemcitabine—lung cancer	8.85e-05	0.000784	CcSEcCtD
Pimozide—Decreased appetite—Docetaxel—lung cancer	8.72e-05	0.000772	CcSEcCtD
Pimozide—Gastrointestinal disorder—Docetaxel—lung cancer	8.66e-05	0.000767	CcSEcCtD
Pimozide—Asthenia—Etoposide—lung cancer	8.66e-05	0.000767	CcSEcCtD
Pimozide—Connective tissue disorder—Doxorubicin—lung cancer	8.66e-05	0.000767	CcSEcCtD
Pimozide—Nausea—Irinotecan—lung cancer	8.62e-05	0.000763	CcSEcCtD
Pimozide—Constipation—Docetaxel—lung cancer	8.58e-05	0.00076	CcSEcCtD
Pimozide—Pruritus—Etoposide—lung cancer	8.54e-05	0.000756	CcSEcCtD
Pimozide—Visual impairment—Doxorubicin—lung cancer	8.49e-05	0.000752	CcSEcCtD
Pimozide—Asthenia—Paclitaxel—lung cancer	8.49e-05	0.000752	CcSEcCtD
Pimozide—Nausea—Gemcitabine—lung cancer	8.39e-05	0.000744	CcSEcCtD
Pimozide—Vomiting—Cisplatin—lung cancer	8.38e-05	0.000742	CcSEcCtD
Pimozide—Pruritus—Paclitaxel—lung cancer	8.37e-05	0.000742	CcSEcCtD
Pimozide—Vision blurred—Methotrexate—lung cancer	8.35e-05	0.000739	CcSEcCtD
Pimozide—Rash—Cisplatin—lung cancer	8.31e-05	0.000736	CcSEcCtD
Pimozide—Dermatitis—Cisplatin—lung cancer	8.3e-05	0.000735	CcSEcCtD
Pimozide—Diarrhoea—Etoposide—lung cancer	8.26e-05	0.000731	CcSEcCtD
Pimozide—Eye disorder—Doxorubicin—lung cancer	8.23e-05	0.000729	CcSEcCtD
Pimozide—Anaemia—Methotrexate—lung cancer	8.19e-05	0.000725	CcSEcCtD
Pimozide—Cardiac disorder—Doxorubicin—lung cancer	8.18e-05	0.000724	CcSEcCtD
Pimozide—Diarrhoea—Paclitaxel—lung cancer	8.1e-05	0.000717	CcSEcCtD
Pimozide—Dizziness—Etoposide—lung cancer	7.98e-05	0.000707	CcSEcCtD
Pimozide—Leukopenia—Methotrexate—lung cancer	7.93e-05	0.000702	CcSEcCtD
Pimozide—Dizziness—Paclitaxel—lung cancer	7.82e-05	0.000693	CcSEcCtD
Pimozide—Nausea—Cisplatin—lung cancer	7.82e-05	0.000693	CcSEcCtD
Pimozide—ABCB1—lymph node—lung cancer	7.74e-05	0.0032	CbGeAlD
Pimozide—Mental disorder—Doxorubicin—lung cancer	7.72e-05	0.000684	CcSEcCtD
Pimozide—Convulsion—Methotrexate—lung cancer	7.67e-05	0.00068	CcSEcCtD
Pimozide—Vomiting—Etoposide—lung cancer	7.67e-05	0.00068	CcSEcCtD
Pimozide—Rash—Etoposide—lung cancer	7.61e-05	0.000674	CcSEcCtD
Pimozide—Dermatitis—Etoposide—lung cancer	7.6e-05	0.000673	CcSEcCtD
Pimozide—Headache—Etoposide—lung cancer	7.56e-05	0.00067	CcSEcCtD
Pimozide—Chest pain—Methotrexate—lung cancer	7.54e-05	0.000668	CcSEcCtD
Pimozide—Myalgia—Methotrexate—lung cancer	7.54e-05	0.000668	CcSEcCtD
Pimozide—Vomiting—Paclitaxel—lung cancer	7.52e-05	0.000666	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.49e-05	0.000663	CcSEcCtD
Pimozide—Rash—Paclitaxel—lung cancer	7.46e-05	0.000661	CcSEcCtD
Pimozide—Dermatitis—Paclitaxel—lung cancer	7.45e-05	0.00066	CcSEcCtD
Pimozide—Headache—Paclitaxel—lung cancer	7.41e-05	0.000657	CcSEcCtD
Pimozide—Muscle spasms—Doxorubicin—lung cancer	7.37e-05	0.000653	CcSEcCtD
Pimozide—Vision blurred—Doxorubicin—lung cancer	7.23e-05	0.00064	CcSEcCtD
Pimozide—Asthenia—Docetaxel—lung cancer	7.2e-05	0.000637	CcSEcCtD
Pimozide—Nausea—Etoposide—lung cancer	7.17e-05	0.000635	CcSEcCtD
Pimozide—Pruritus—Docetaxel—lung cancer	7.1e-05	0.000629	CcSEcCtD
Pimozide—Nervous system disorder—Methotrexate—lung cancer	7.09e-05	0.000628	CcSEcCtD
Pimozide—Anaemia—Doxorubicin—lung cancer	7.09e-05	0.000628	CcSEcCtD
Pimozide—Agitation—Doxorubicin—lung cancer	7.05e-05	0.000624	CcSEcCtD
Pimozide—Nausea—Paclitaxel—lung cancer	7.03e-05	0.000623	CcSEcCtD
Pimozide—Skin disorder—Methotrexate—lung cancer	7.02e-05	0.000622	CcSEcCtD
Pimozide—Hyperhidrosis—Methotrexate—lung cancer	6.99e-05	0.000619	CcSEcCtD
Pimozide—Anorexia—Methotrexate—lung cancer	6.89e-05	0.00061	CcSEcCtD
Pimozide—Syncope—Doxorubicin—lung cancer	6.88e-05	0.000609	CcSEcCtD
Pimozide—Leukopenia—Doxorubicin—lung cancer	6.86e-05	0.000608	CcSEcCtD
Pimozide—Diarrhoea—Docetaxel—lung cancer	6.86e-05	0.000608	CcSEcCtD
Pimozide—Palpitations—Doxorubicin—lung cancer	6.78e-05	0.0006	CcSEcCtD
Pimozide—Hypotension—Methotrexate—lung cancer	6.75e-05	0.000598	CcSEcCtD
Pimozide—Loss of consciousness—Doxorubicin—lung cancer	6.74e-05	0.000597	CcSEcCtD
Pimozide—Convulsion—Doxorubicin—lung cancer	6.64e-05	0.000589	CcSEcCtD
Pimozide—Dizziness—Docetaxel—lung cancer	6.63e-05	0.000588	CcSEcCtD
Pimozide—Hypertension—Doxorubicin—lung cancer	6.62e-05	0.000587	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methotrexate—lung cancer	6.59e-05	0.000583	CcSEcCtD
Pimozide—Insomnia—Methotrexate—lung cancer	6.54e-05	0.000579	CcSEcCtD
Pimozide—Chest pain—Doxorubicin—lung cancer	6.53e-05	0.000578	CcSEcCtD
Pimozide—Myalgia—Doxorubicin—lung cancer	6.53e-05	0.000578	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.48e-05	0.000574	CcSEcCtD
Pimozide—Somnolence—Methotrexate—lung cancer	6.43e-05	0.000569	CcSEcCtD
Pimozide—Dry mouth—Doxorubicin—lung cancer	6.39e-05	0.000566	CcSEcCtD
Pimozide—Vomiting—Docetaxel—lung cancer	6.38e-05	0.000565	CcSEcCtD
Pimozide—Rash—Docetaxel—lung cancer	6.32e-05	0.00056	CcSEcCtD
Pimozide—Dermatitis—Docetaxel—lung cancer	6.32e-05	0.00056	CcSEcCtD
Pimozide—Decreased appetite—Methotrexate—lung cancer	6.28e-05	0.000557	CcSEcCtD
Pimozide—Headache—Docetaxel—lung cancer	6.28e-05	0.000557	CcSEcCtD
Pimozide—Gastrointestinal disorder—Methotrexate—lung cancer	6.24e-05	0.000553	CcSEcCtD
Pimozide—Shock—Doxorubicin—lung cancer	6.16e-05	0.000546	CcSEcCtD
Pimozide—Nervous system disorder—Doxorubicin—lung cancer	6.14e-05	0.000544	CcSEcCtD
Pimozide—Tachycardia—Doxorubicin—lung cancer	6.11e-05	0.000541	CcSEcCtD
Pimozide—Skin disorder—Doxorubicin—lung cancer	6.08e-05	0.000539	CcSEcCtD
Pimozide—Hyperhidrosis—Doxorubicin—lung cancer	6.05e-05	0.000536	CcSEcCtD
Pimozide—Anorexia—Doxorubicin—lung cancer	5.97e-05	0.000529	CcSEcCtD
Pimozide—Nausea—Docetaxel—lung cancer	5.96e-05	0.000528	CcSEcCtD
Pimozide—Hypotension—Doxorubicin—lung cancer	5.85e-05	0.000518	CcSEcCtD
Pimozide—Urticaria—Methotrexate—lung cancer	5.74e-05	0.000509	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.7e-05	0.000505	CcSEcCtD
Pimozide—Insomnia—Doxorubicin—lung cancer	5.66e-05	0.000501	CcSEcCtD
Pimozide—Somnolence—Doxorubicin—lung cancer	5.56e-05	0.000493	CcSEcCtD
Pimozide—Decreased appetite—Doxorubicin—lung cancer	5.44e-05	0.000482	CcSEcCtD
Pimozide—Gastrointestinal disorder—Doxorubicin—lung cancer	5.4e-05	0.000479	CcSEcCtD
Pimozide—Constipation—Doxorubicin—lung cancer	5.35e-05	0.000474	CcSEcCtD
Pimozide—Asthenia—Methotrexate—lung cancer	5.19e-05	0.000459	CcSEcCtD
Pimozide—Pruritus—Methotrexate—lung cancer	5.11e-05	0.000453	CcSEcCtD
Pimozide—Urticaria—Doxorubicin—lung cancer	4.97e-05	0.00044	CcSEcCtD
Pimozide—Diarrhoea—Methotrexate—lung cancer	4.95e-05	0.000438	CcSEcCtD
Pimozide—Dizziness—Methotrexate—lung cancer	4.78e-05	0.000423	CcSEcCtD
Pimozide—Vomiting—Methotrexate—lung cancer	4.6e-05	0.000407	CcSEcCtD
Pimozide—Rash—Methotrexate—lung cancer	4.56e-05	0.000404	CcSEcCtD
Pimozide—Dermatitis—Methotrexate—lung cancer	4.55e-05	0.000403	CcSEcCtD
Pimozide—Headache—Methotrexate—lung cancer	4.53e-05	0.000401	CcSEcCtD
Pimozide—Asthenia—Doxorubicin—lung cancer	4.49e-05	0.000398	CcSEcCtD
Pimozide—Pruritus—Doxorubicin—lung cancer	4.43e-05	0.000392	CcSEcCtD
Pimozide—Nausea—Methotrexate—lung cancer	4.29e-05	0.00038	CcSEcCtD
Pimozide—Diarrhoea—Doxorubicin—lung cancer	4.28e-05	0.000379	CcSEcCtD
Pimozide—Dizziness—Doxorubicin—lung cancer	4.14e-05	0.000367	CcSEcCtD
Pimozide—Vomiting—Doxorubicin—lung cancer	3.98e-05	0.000353	CcSEcCtD
Pimozide—Rash—Doxorubicin—lung cancer	3.95e-05	0.00035	CcSEcCtD
Pimozide—Dermatitis—Doxorubicin—lung cancer	3.94e-05	0.000349	CcSEcCtD
Pimozide—Headache—Doxorubicin—lung cancer	3.92e-05	0.000347	CcSEcCtD
Pimozide—Nausea—Doxorubicin—lung cancer	3.72e-05	0.000329	CcSEcCtD
Pimozide—CALM2—Disease—MYC—lung cancer	1.64e-06	1.16e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—lung cancer	1.64e-06	1.16e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—EP300—lung cancer	1.64e-06	1.16e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RAF1—lung cancer	1.63e-06	1.16e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RAF1—lung cancer	1.63e-06	1.16e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EP300—lung cancer	1.63e-06	1.16e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.63e-06	1.16e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—EP300—lung cancer	1.63e-06	1.16e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—EP300—lung cancer	1.63e-06	1.15e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—PIK3CA—lung cancer	1.62e-06	1.15e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTM1—lung cancer	1.62e-06	1.15e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—SRC—lung cancer	1.62e-06	1.15e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ERBB2—lung cancer	1.62e-06	1.14e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ERBB2—lung cancer	1.62e-06	1.14e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CD—lung cancer	1.62e-06	1.14e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—lung cancer	1.62e-06	1.14e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PIK3CA—lung cancer	1.61e-06	1.14e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EP300—lung cancer	1.61e-06	1.14e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—lung cancer	1.6e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—lung cancer	1.6e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MTOR—lung cancer	1.6e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CB—lung cancer	1.6e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CB—lung cancer	1.6e-06	1.13e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MTOR—lung cancer	1.6e-06	1.13e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—lung cancer	1.6e-06	1.13e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—SRC—lung cancer	1.59e-06	1.13e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—SRC—lung cancer	1.59e-06	1.12e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCL8—lung cancer	1.59e-06	1.12e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—lung cancer	1.58e-06	1.12e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—HRAS—lung cancer	1.57e-06	1.11e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—EP300—lung cancer	1.57e-06	1.11e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—EP300—lung cancer	1.57e-06	1.11e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—lung cancer	1.57e-06	1.11e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—lung cancer	1.57e-06	1.11e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—SRC—lung cancer	1.56e-06	1.11e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—KRAS—lung cancer	1.56e-06	1.11e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—lung cancer	1.56e-06	1.1e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CG—lung cancer	1.56e-06	1.1e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NRAS—lung cancer	1.56e-06	1.1e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—lung cancer	1.56e-06	1.1e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—PIK3CA—lung cancer	1.56e-06	1.1e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—lung cancer	1.55e-06	1.1e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—lung cancer	1.55e-06	1.1e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—lung cancer	1.55e-06	1.1e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—lung cancer	1.54e-06	1.09e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP1A1—lung cancer	1.53e-06	1.09e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCL8—lung cancer	1.53e-06	1.09e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCL8—lung cancer	1.53e-06	1.09e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—lung cancer	1.53e-06	1.08e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NRAS—lung cancer	1.53e-06	1.08e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CB—lung cancer	1.53e-06	1.08e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NRAS—lung cancer	1.53e-06	1.08e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KRAS—lung cancer	1.53e-06	1.08e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—HRAS—lung cancer	1.52e-06	1.08e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—HRAS—lung cancer	1.52e-06	1.08e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.52e-06	1.08e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ERCC2—lung cancer	1.52e-06	1.08e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—lung cancer	1.52e-06	1.07e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—lung cancer	1.52e-06	1.07e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—lung cancer	1.51e-06	1.07e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—KRAS—lung cancer	1.51e-06	1.07e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—KRAS—lung cancer	1.51e-06	1.07e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—lung cancer	1.51e-06	1.07e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—lung cancer	1.51e-06	1.07e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—PIK3CA—lung cancer	1.5e-06	1.06e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—PIK3CA—lung cancer	1.5e-06	1.06e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NRAS—lung cancer	1.5e-06	1.06e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—HRAS—lung cancer	1.5e-06	1.06e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CB—lung cancer	1.5e-06	1.06e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK3—lung cancer	1.49e-06	1.06e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—HRAS—lung cancer	1.49e-06	1.05e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—POMC—lung cancer	1.48e-06	1.05e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—lung cancer	1.48e-06	1.05e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCND1—lung cancer	1.48e-06	1.05e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—JUN—lung cancer	1.47e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—lung cancer	1.47e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—lung cancer	1.47e-06	1.04e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK3—lung cancer	1.47e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—lung cancer	1.47e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—lung cancer	1.47e-06	1.04e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK3—lung cancer	1.46e-06	1.04e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—lung cancer	1.46e-06	1.03e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—lung cancer	1.46e-06	1.03e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—lung cancer	1.45e-06	1.03e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CREBBP—lung cancer	1.44e-06	1.02e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.44e-06	1.02e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—HRAS—lung cancer	1.44e-06	1.02e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—lung cancer	1.44e-06	1.02e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—PIK3CA—lung cancer	1.44e-06	1.02e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—lung cancer	1.43e-06	1.01e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CDKN1A—lung cancer	1.43e-06	1.01e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCND1—lung cancer	1.43e-06	1.01e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCND1—lung cancer	1.43e-06	1.01e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—lung cancer	1.43e-06	1.01e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—JUN—lung cancer	1.43e-06	1.01e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—JUN—lung cancer	1.43e-06	1.01e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PTEN—lung cancer	1.43e-06	1.01e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—lung cancer	1.42e-06	1.01e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—lung cancer	1.42e-06	1.01e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—lung cancer	1.42e-06	1e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CB—lung cancer	1.41e-06	9.97e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.4e-06	9.92e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—lung cancer	1.4e-06	9.92e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—lung cancer	1.4e-06	9.88e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—lung cancer	1.4e-06	9.88e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—lung cancer	1.39e-06	9.86e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—HRAS—lung cancer	1.39e-06	9.85e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—HRAS—lung cancer	1.39e-06	9.85e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—lung cancer	1.39e-06	9.84e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—PIK3CA—lung cancer	1.39e-06	9.83e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—PIK3CA—lung cancer	1.39e-06	9.83e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—lung cancer	1.39e-06	9.82e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—lung cancer	1.39e-06	9.82e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CDKN1A—lung cancer	1.38e-06	9.78e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CDKN1A—lung cancer	1.38e-06	9.78e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PTEN—lung cancer	1.38e-06	9.76e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PTEN—lung cancer	1.38e-06	9.76e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—lung cancer	1.38e-06	9.75e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—lung cancer	1.37e-06	9.7e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CD—lung cancer	1.37e-06	9.69e-06	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—lung cancer	1.37e-06	9.66e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EP300—lung cancer	1.36e-06	9.62e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—lung cancer	1.36e-06	9.6e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—lung cancer	1.35e-06	9.57e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—lung cancer	1.35e-06	9.52e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—lung cancer	1.35e-06	9.52e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KRAS—lung cancer	1.34e-06	9.48e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—lung cancer	1.33e-06	9.43e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—lung cancer	1.33e-06	9.43e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—HRAS—lung cancer	1.33e-06	9.4e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—lung cancer	1.33e-06	9.39e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTEN—lung cancer	1.32e-06	9.37e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SRC—lung cancer	1.32e-06	9.36e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KRAS—lung cancer	1.32e-06	9.33e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOA1—lung cancer	1.32e-06	9.32e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KRAS—lung cancer	1.32e-06	9.31e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EP300—lung cancer	1.32e-06	9.31e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EP300—lung cancer	1.32e-06	9.31e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—lung cancer	1.31e-06	9.3e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HRAS—lung cancer	1.3e-06	9.18e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KRAS—lung cancer	1.29e-06	9.16e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTEN—lung cancer	1.29e-06	9.14e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—lung cancer	1.29e-06	9.11e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—HRAS—lung cancer	1.29e-06	9.1e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—HRAS—lung cancer	1.29e-06	9.1e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SRC—lung cancer	1.28e-06	9.05e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SRC—lung cancer	1.28e-06	9.05e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—lung cancer	1.27e-06	9.02e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NRAS—lung cancer	1.27e-06	9e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—lung cancer	1.27e-06	9e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—lung cancer	1.27e-06	8.99e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—EP300—lung cancer	1.26e-06	8.93e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—lung cancer	1.25e-06	8.81e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—lung cancer	1.25e-06	8.81e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—lung cancer	1.24e-06	8.79e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—lung cancer	1.23e-06	8.73e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—lung cancer	1.23e-06	8.73e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—EP300—lung cancer	1.23e-06	8.72e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PIK3CA—lung cancer	1.23e-06	8.71e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NRAS—lung cancer	1.23e-06	8.71e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NRAS—lung cancer	1.23e-06	8.71e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—lung cancer	1.23e-06	8.71e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—lung cancer	1.23e-06	8.71e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—lung cancer	1.23e-06	8.7e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—lung cancer	1.23e-06	8.7e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK3—lung cancer	1.22e-06	8.62e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTEN—lung cancer	1.22e-06	8.62e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PIK3CA—lung cancer	1.21e-06	8.57e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PIK3CA—lung cancer	1.21e-06	8.57e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.21e-06	8.56e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PIK3CA—lung cancer	1.21e-06	8.55e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PIK3CA—lung cancer	1.2e-06	8.51e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CG—lung cancer	1.2e-06	8.51e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CB—lung cancer	1.19e-06	8.45e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—lung cancer	1.19e-06	8.43e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.19e-06	8.42e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—lung cancer	1.18e-06	8.38e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—lung cancer	1.18e-06	8.37e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK3—lung cancer	1.18e-06	8.34e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK3—lung cancer	1.18e-06	8.34e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—lung cancer	1.17e-06	8.3e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—lung cancer	1.17e-06	8.29e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—lung cancer	1.17e-06	8.28e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3CA—lung cancer	1.16e-06	8.23e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3CA—lung cancer	1.16e-06	8.23e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—EP300—lung cancer	1.16e-06	8.22e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—lung cancer	1.16e-06	8.2e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—lung cancer	1.15e-06	8.14e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—lung cancer	1.15e-06	8.11e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—lung cancer	1.15e-06	8.11e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—lung cancer	1.15e-06	8.11e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—POMC—lung cancer	1.14e-06	8.1e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HRAS—lung cancer	1.14e-06	8.06e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—lung cancer	1.13e-06	8.03e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—lung cancer	1.13e-06	8.03e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—lung cancer	1.12e-06	7.93e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—lung cancer	1.12e-06	7.93e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—HRAS—lung cancer	1.12e-06	7.93e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HRAS—lung cancer	1.12e-06	7.92e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CREBBP—lung cancer	1.11e-06	7.89e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HRAS—lung cancer	1.1e-06	7.79e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KRAS—lung cancer	1.09e-06	7.75e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—lung cancer	1.09e-06	7.72e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—lung cancer	1.07e-06	7.59e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—lung cancer	1.07e-06	7.58e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KRAS—lung cancer	1.06e-06	7.49e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KRAS—lung cancer	1.06e-06	7.49e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CD—lung cancer	1.06e-06	7.48e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—lung cancer	1.05e-06	7.45e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—lung cancer	1.04e-06	7.38e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTEN—lung cancer	1.03e-06	7.3e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—lung cancer	1.01e-06	7.12e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CA—lung cancer	1.01e-06	7.12e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—lung cancer	9.9e-07	7e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—lung cancer	9.89e-07	7e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—lung cancer	9.87e-07	6.99e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—lung cancer	9.87e-07	6.98e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—EP300—lung cancer	9.84e-07	6.96e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—lung cancer	9.82e-07	6.95e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—lung cancer	9.73e-07	6.89e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CA—lung cancer	9.73e-07	6.88e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CA—lung cancer	9.73e-07	6.88e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—lung cancer	9.72e-07	6.88e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—lung cancer	9.5e-07	6.73e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—lung cancer	9.5e-07	6.73e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—lung cancer	9.41e-07	6.66e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—lung cancer	9.41e-07	6.66e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CA—lung cancer	9.34e-07	6.61e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HRAS—lung cancer	9.3e-07	6.58e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CB—lung cancer	9.21e-07	6.52e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—lung cancer	9.13e-07	6.46e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CA—lung cancer	9.11e-07	6.45e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HRAS—lung cancer	9e-07	6.37e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HRAS—lung cancer	9e-07	6.37e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—lung cancer	8.9e-07	6.3e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—lung cancer	8.61e-07	6.1e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—lung cancer	8.61e-07	6.1e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CA—lung cancer	8.59e-07	6.08e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—lung cancer	8.21e-07	5.81e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTEN—lung cancer	7.96e-07	5.63e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—lung cancer	7.95e-07	5.62e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—lung cancer	7.95e-07	5.62e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—lung cancer	7.63e-07	5.4e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—EP300—lung cancer	7.59e-07	5.37e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—lung cancer	7.45e-07	5.27e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CA—lung cancer	7.28e-07	5.15e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—lung cancer	7.02e-07	4.97e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—lung cancer	5.94e-07	4.21e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CA—lung cancer	5.62e-07	3.97e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—lung cancer	4.59e-07	3.25e-06	CbGpPWpGaD
